CD14+ Monocytes
Since 2007, CellMade™ provides high-purity (>95%) CD14+ Monocytes for MAT and CRA. Available in single, 4-donor, and premium 8-donor pools. Ph. Eur. 2.6.30 compliant and assay-ready.
Since 2007, CellMade™ has been a foundational expert in the development of primary human cell models. While PBMCs are a versatile tool, our Purified CD14+ Monocytes represent the next level of assay precision. These are not merely isolated cells; they are functionally qualified, high-purity reagents engineered to provide the most direct and sensitive readout for pyrogenicity and cytokine release, meeting the most stringent global regulatory standards, including Ph. Eur. 2.6.30.
Why Choose Purified CD14+ Monocytes Over PBMCs?
While PBMCs are suitable for general screening, purified CD14+ monocytes offer distinct technical advantages for high-stakes pharmaceutical testing:
- Superior Signal-to-Noise Ratio: By removing lymphocytes (T, B, and NK cells), you eliminate "background noise" and non-specific cytokine interference, leading to cleaner, more reproducible data.
- Enhanced Sensitivity for MAT: In the Monocyte Activation Test, the monocyte is the primary responding cell. Using a purified population allows for a higher effective concentration of responding cells per well, increasing the detection limit for trace pyrogens.
- Defined Cell Ratios: Pure populations allow for precise calculation of drug-to-cell ratios or Multiplicity of Infection (MOI), ensuring experimental consistency that is impossible with the variable monocyte percentages found in raw PBMCs.
Specific Applications & Research Use
CellMade™ CD14+ Monocytes are optimized for a wide range of high-precision applications:
- Monocyte Activation Test (MAT): The preferred in vitro alternative to animal-based pyrogen testing. Our cells are pre-validated for sensitivity to both endotoxin and non-endotoxin pyrogens.
- Cytokine Release Assays (CRA): Essential for safety assessment of biologics and biosimilars to predict potential cytokine storm risks.
- Cellular Differentiation: The ideal starting material for generating:
- Monocyte-Derived Macrophages (MDMs): For studying phagocytosis, inflammation, and tissue repair.
- Monocyte-Derived Dendritic Cells (moDCs): For antigen presentation and T-cell activation studies.
- Functional Assays: High-purity models for studying chemotaxis, transmigration, and metabolic flux in the innate immune system.
Strategic Market Formats
To ensure the highest post-thaw recovery and metabolic activity, we provide our purified CD14+ monocytes in optimized concentrations:
|
Format |
Cell Count per Vial |
Common Use Case |
|
Standard |
5 Million (5x 106) |
Targeted R&D, pilot cytokine assays, and moDC differentiation. |
|
Premium Yield |
10 Million (1x 107) |
Industry Standard: Optimized for validated MAT and high-density profiling. |
The CellMade™ Premium: Donor Configurations
- Single Donor: Critical for identifying donor-specific sensitivities and investigating individual variability in drug response.
- 4-Donor Pooled: A robust entry point for standardized screening that meets the minimum requirements for MAT.
- Premium 8-Donor Pooled (The CellMade™ Standard): * Regulatory Superiority: Directly aligns with the Ph. Eur. recommendation to use 8+ donors to maximize assay sensitivity and prevent false negatives.
- Broad Representation: Mirrors the "average human" immune response by integrating a diverse spectrum of HLA types.
Quality, Safety, and Ethics
Pre-Qualified Functional Characterization
- Purity: Guaranteed >95% CD14+ by flow cytometry.
- Functional Benchmarking: Pre-screened for reliable secretion of IL-6, IL-1β, and TNF-α.
- Viability: Guaranteed >90% post-thaw viability.
Bio-Ethical Sourcing & Safety
- Informed Consent: All cells are derived from healthy volunteers with full, written informed consent.
- Traceability: Sourced under strict IRB/Ethics Committee approved protocols with full documentation.
- Pathogen Testing: Certified negative for HIV-1/2, HBV, and HCV. Verified free of Mycoplasma, bacteria, and fungi.
Experience Matters: Since 2007
With nearly two decades of experience, CellMade™ understands that the Monocyte Activation Test is only as reliable as the cells used. Our long-standing history in the primary cell market ensures that our purification processes preserve the delicate signaling pathways required for accurate detection.
The CellMade™ Advantage
When you choose CellMade™ Functionally Characterized Human CD14+ Monocytes, you gain more than cells in a vial; you gain a comprehensive analytical partnership.
- Expert Technical Support: Every solution is backed by direct access to validation reports, detailed kit inserts, and expert consultation to help you optimize your specific workflow.
Procurement & Implementation
Access to CellMade™ Pharmaceutical Quality Control products is restricted to ensure peak performance and regulatory alignment. These products are available exclusively under a purchase license following a mandatory technical onboarding process:
-
Feasibility & Method Development: Initial assessment and protocol design tailored to your specific application.
-
Validation & Transfer: Product-specific validation followed by a formal method transfer to your facility.
-
Implementation: Comprehensive on-site training to ensure seamless integration into your QC workflow.
Products
| Ref | Products | Description | Price |
|---|---|---|---|
| CM102211A | CellMade™ functionally characterized human CD14+ monocytes | Cryoconserved, single donor, 10 millions cells (1 vial) |
740.00 € |
| CM102211B | CellMade™ functionally characterized human CD14+ monocytes | Cryoconserved, single donor, 25 million cells (1 vial) |
1757.50 € |
| CM1022P1A | CellMade™ functionally characterized human CD14+ monocytes | Cryoconserved, 4-donor pooled, 10 millions cells (1 vial) |
1480.00 € |
| CM1022P1B | CellMade™ functionally characterized human CD14+ monocytes | Cryoconserved, 4-donor pooled, 25 million cells (1 vial) |
3515.00 € |
| CM1022PP1A | CellMade™ functionally characterized human CD14+ monocytes | Cryoconserved, 8-donor pooled, 10 millions cells (1 vial) |
2220.00 € |
| CM1022PP1B | CellMade™ functionally characterized human CD14+ monocytes | Cryoconserved, 8-donor pooled, 25 million cells (1 vial) |
5272.50 € |
| CM102211BF | CellMade™ functionally characterized human CD14+ monocytes | T25 flask, single donor, 25 millions cells |
3142.44 € |
| CM1022P1BF | CellMade™ functionally characterized human CD14+ monocytes | T25 flask, 4-donor pooled, 25 millions cells |
6248.89 € |
| CM1022PP1BF | CellMade™ functionally characterized human CD14+ monocytes | T25 flask, 4-donor pooled, 25 millions cells |
9373.33 € |
| CM1022PP1BF | CellMade™ functionally characterized human CD14+ monocytes | T25 flask, 4-donor pooled, 25 millions cells |
9373.33 € |